Perrigo (PRGO) Asset Writedowns and Impairment (2015 - 2026)
Perrigo (PRGO) reported Asset Writedowns and Impairment of $330.8 million for Q1 2026, up 10570.97% year-over-year from N/an in Q1 2025, and down 75.65% quarter-over-quarter from $1.4 billion in Q4 2025.
Perrigo (PRGO) Asset Writedowns and Impairment (2015 - 2026) Analysis & Trends
Perrigo (PRGO) has 11 years of Asset Writedowns and Impairment data on file, last reported at $330.8 million in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $330.8 million, up 10570.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 1183.83% YoY), and the FY2025 annual result was $1.4 billion, up 1433.3% from the prior year.
- Asset Writedowns and Impairment eased to $330.8 million in Q1 2026 per PRGO's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $1.4 billion in Q4 2025 and troughed at $1.5 million in Q2 2025.
- A 4-year average of $234.1 million and a median of $36.4 million in 2024 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment tumbled 95.6% in 2025, then jumped 10570.97% in 2026.
- A 4-year view of Asset Writedowns and Impairment shows it stood at $90.0 million in 2023, then tumbled by 57.11% to $38.6 million in 2024, then jumped by 3419.43% to $1.4 billion in 2025, then sank by 75.65% to $330.8 million in 2026.
- Business Quant data shows PRGO's Asset Writedowns and Impairment at $330.8 million in Q1 2026, $1.4 billion in Q4 2025, and $1.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 330.80 Mn |
| Mar 28, 2026 | 330.80 Mn |
| Dec 31, 2025 | 1.36 Bn |
| Dec 31, 2025 | 1.36 Bn |
| Jun 28, 2025 | 1.50 Mn |
| Jun 28, 2025 | 1.50 Mn |
| Mar 29, 2025 | 3.10 Mn |
| Mar 29, 2025 | 3.10 Mn |
| Dec 31, 2024 | 38.60 Mn |
| Dec 31, 2024 | 38.60 Mn |
| Sep 28, 2024 | 16.20 Mn |
| Sep 28, 2024 | 16.20 Mn |
| Jun 29, 2024 | 34.10 Mn |
| Jun 29, 2024 | 34.10 Mn |
| Dec 31, 2023 | 90.00 Mn |
| Dec 31, 2023 | 90.00 Mn |
| Dec 31, 2021 | 11.00 Mn |
| Dec 31, 2021 | 11.00 Mn |
| Oct 2, 2021 | 3.50 Mn |
| Oct 2, 2021 | 3.50 Mn |